Confronting the burden of tobacco-related lung cancer in Europe in the next decades

Kevin ten Haaf

doi:10.1016/j.lanepe.2021.100085

Confronting the burden of tobacco-related lung cancer in Europe in the next decades

Kevin ten Haaf

Public Health

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

10 Downloads (Pure)

Original language	English
Article number	100085
Journal	The Lancet Regional Health - Europe
Volume	4
Early online date	22 Mar 2021
DOIs	https://doi.org/10.1016/j.lanepe.2021.100085
Publication status	Published - May 2021

Bibliographical note

Funding Information:
Dr. ten Haaf reports grants from European Union (Horizon 2020), grants from University of Zurich, Switzerland, non-financial support from International Association for the Study of Lung Cancer, non-financial support from International Association for the Study of Lung Cancer, grants from Cancer Research UK, non-financial support from Russian Society of Clinical Oncology, non-financial support and other from BIOMEDICAL RESEARCH IN ENDSTAGE AND OBSTRUCTIVE LUNG DISEASE HANNOVER (BREATH), grants from NIH/National Cancer Institute, outside the submitted work.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.lanepe.2021.100085Licence: CC BY-NC-ND

Confronting the burden of tobacco-related lung cancer in Europe in the next decadesFinal published version, 240 KBLicence: CC BY-NC-ND

Cite this

@article{a0266768cb414c72a6df535a7ab48c89,

title = "Confronting the burden of tobacco-related lung cancer in Europe in the next decades",

author = "{ten Haaf}, Kevin",

note = "Funding Information: Dr. ten Haaf reports grants from European Union (Horizon 2020), grants from University of Zurich, Switzerland, non-financial support from International Association for the Study of Lung Cancer, non-financial support from International Association for the Study of Lung Cancer, grants from Cancer Research UK, non-financial support from Russian Society of Clinical Oncology, non-financial support and other from BIOMEDICAL RESEARCH IN ENDSTAGE AND OBSTRUCTIVE LUNG DISEASE HANNOVER (BREATH), grants from NIH/National Cancer Institute, outside the submitted work.",

year = "2021",

month = may,

doi = "10.1016/j.lanepe.2021.100085",

language = "English",

volume = "4",

}

TY - JOUR

T1 - Confronting the burden of tobacco-related lung cancer in Europe in the next decades

AU - ten Haaf, Kevin

N1 - Funding Information: Dr. ten Haaf reports grants from European Union (Horizon 2020), grants from University of Zurich, Switzerland, non-financial support from International Association for the Study of Lung Cancer, non-financial support from International Association for the Study of Lung Cancer, grants from Cancer Research UK, non-financial support from Russian Society of Clinical Oncology, non-financial support and other from BIOMEDICAL RESEARCH IN ENDSTAGE AND OBSTRUCTIVE LUNG DISEASE HANNOVER (BREATH), grants from NIH/National Cancer Institute, outside the submitted work.

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85111377384&partnerID=8YFLogxK

U2 - 10.1016/j.lanepe.2021.100085

DO - 10.1016/j.lanepe.2021.100085

M3 - Comment/Letter to the editor

C2 - 34557813

AN - SCOPUS:85111377384

VL - 4

JO - The Lancet Regional Health - Europe

JF - The Lancet Regional Health - Europe

M1 - 100085

ER -

Confronting the burden of tobacco-related lung cancer in Europe in the next decades

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this